These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6553424)

  • 1. [Reactions initiating blood coagulation].
    Zubairov DM; Baĭkeev RF
    Ukr Biokhim Zh (1978); 1983; 55(3):281-4. PubMed ID: 6553424
    [No Abstract]   [Full Text] [Related]  

  • 2. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
    Scott CF; Carrell RW; Glaser CB; Lewis JH; Colman RW
    Trans Assoc Am Physicians; 1985; 98():344-51. PubMed ID: 3879844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
    Rosenberg RD
    Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
    [No Abstract]   [Full Text] [Related]  

  • 5. Selected topics on blood coagulation.
    Triantaphyllopoulos E; Triantaphyllopoulos DC
    CRC Crit Rev Biochem; 1973 Aug; 1(3):305-80. PubMed ID: 4609689
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Inhibition of blood coagulation factor XI-XII by monoclonal IgM.
    Valentin IR; Rimon A; Lahav M
    Isr J Med Sci; 1975 Dec; 11(12):1392. PubMed ID: 815201
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system.
    Laake K; Osterud B
    Thromb Res; 1974 Dec; 5(6):759-72. PubMed ID: 4280635
    [No Abstract]   [Full Text] [Related]  

  • 8. [Salicylic acid derivatives used as anticoagulants].
    Bruhn HD
    Verh Dtsch Ges Inn Med; 1971; 77():1035-7. PubMed ID: 5155959
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

  • 10. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP
    Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in the understanding of contact activation reactions.
    Griffin JH; Cochrane CG
    Semin Thromb Hemost; 1979; 5(4):254-73. PubMed ID: 386517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombocytic complications in a patient with an inhibitor against the contact factor].
    Papaian LP; Litmanovich KIu
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):56-9. PubMed ID: 1273067
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alkaline and acid phosphatases on clotting: Evidence that alkaline phosphatase enhances activation of factor IX by SF, and that acid phosphatase enhances plasmatic anti-SF.
    Iatridis PG; Ferguson JH
    Thromb Diath Haemorrh; 1966 May; 15(3):365-80. PubMed ID: 5989024
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of IgM antibodies which inhibit the contact activation of blood coagulation.
    Criel A; Collen D; Masson PL
    Thromb Res; 1978 May; 12(5):883-92. PubMed ID: 566967
    [No Abstract]   [Full Text] [Related]  

  • 17. Bovine plasma thromboplastin antecedent (Factor XI) deficiency.
    Kociba GJ; Ratnoff OD; Loeb WF; Wall RL; Heider LE
    J Lab Clin Med; 1969 Jul; 74(1):37-41. PubMed ID: 5256172
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.